Literature DB >> 28950254

Genotype Distribution and Molecular Epidemiology of Hepatitis C Virus in Guangzhou, China: Predominance of Genotype 1b and Increasing Incidence of Genotype 6a.

Guosheng Yuan1, Junwei Liu1, Chengguang Hu1, Huaping Huang1, Minghua Qi1,2, Tao Wu1,3, Weifang Liang1, Yi-Ping Li4, Yong-Yuan Zhang5, Yuanping Zhou1.   

Abstract

BACKGROUND/AIMS: Distribution of Hepatitis C virus (HCV) genotypes vary geographically and may associate with the mode of transmission. Little is known about the molecular epidemiology of HCV infection in Guangzhou, China.
METHODS: A cross-sectional survey included 561 subjects with chronic HCV infection registered at Nanfang Hospital, Southern Medical University, was performed. All residents were invited for a questionnaire interview to collect information about their personal status and commercial blood donation history.
RESULTS: A total of 463 chronic hepatitis C (CHC) patients were finally enrolled. Among the 463 samples, 426 were characterized by partial core-E1 sequences and classified into 7 subtypes: 1b (n=263, 61.7%), 6a (n=86, 20.2%), 2a (n=26, 6.1%), 3b (n=26, 6.1%), 3a (n=22, 5.2%), 6u (n=2, 0.5%), and 4a (n=1, 0.2%). Analysis of genotype-associated risk factors revealed that blood donation and transfusion were strongly associated with subtypes 1b and 2a, while genotype 3b and 6a were more frequent in intravenous drug users.
CONCLUSIONS: Phylogeographic analyses demonstrated that the distribution of HCV genotypes in Guangzhou is complex. Interestingly, 6a has become a local endemic in Guangzhou and may be the second source region to disseminate 6a to other provinces. The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  China; Evolution; Guangdong province; HCV; Molecular epidemiology; Phylogeographic analysis

Mesh:

Substances:

Year:  2017        PMID: 28950254     DOI: 10.1159/000481561

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  6 in total

1.  HCV 6a was expanding and became the predominant subtype among blood donors between 2004 and 2019 in Guangdong, China.

Authors:  Rongsong Du; Ru Xu; Jieting Huang; Hao Wang; Min Wang; Qiao Liao; Zhengang Shan; Huishan Zhong; Yourong Zheng; Xia Rong; Yongshui Fu
Journal:  Virol Sin       Date:  2022-07-13       Impact factor: 6.947

2.  Trends of recent hepatitis C virus infection among HIV-positive men who have sex with men in Taiwan, 2011-2018.

Authors:  Shu-Yuan Ho; Li-Hsin Su; Hsin-Yun Sun; Yu-Shan Huang; Yu-Chung Chuang; Miao-Hui Huang; Wen-Chun Liu; Yi-Ching Su; Pi-Han Lin; Sui-Yuan Chang; Chien-Ching Hung
Journal:  EClinicalMedicine       Date:  2020-06-27

3.  Sofosbuvir-Based Therapies for Patients with Hepatitis C Virus Infection: Real-World Experience in China.

Authors:  Chengguang Hu; Guosheng Yuan; Junwei Liu; Huaping Huang; Yanyu Ren; Yinping Li; Xuefu Chen; Wei Li; Tao Wu; Hong Deng; Yanzhong Peng; Yong-Yuan Zhang; Yuanping Zhou
Journal:  Can J Gastroenterol Hepatol       Date:  2018-11-13

4.  Novel adeno‑associated virus‑based genetic vaccines encoding hepatitis C virus E2 glycoprotein elicit humoral immune responses in mice.

Authors:  Fengqin Zhu; Yibo Wang; Zhen Xu; Haiyang Qu; Hairong Zhang; Lingling Niu; Honglu Xue; Dehuai Jing; Heng He
Journal:  Mol Med Rep       Date:  2018-12-11       Impact factor: 2.952

5.  Transcription Factor MafB Suppresses Type I Interferon Production by CD14+ Monocytes in Patients With Chronic Hepatitis C.

Authors:  Tie-Mei Liu; Han Wang; Dong-Na Zhang; Guang-Ze Zhu
Journal:  Front Microbiol       Date:  2019-08-07       Impact factor: 5.640

Review 6.  Review on the molecular epidemiology of sexually acquired hepatitis C virus infection in the Asia-Pacific region.

Authors:  Chin Pok Chan; Haruka Uemura; Tsz Ho Kwan; Ngai Sze Wong; Shinichi Oka; Denise Pui Chung Chan; Shui Shan Lee
Journal:  J Int AIDS Soc       Date:  2020-09       Impact factor: 5.396

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.